Answers are grounded in this paper and cite their sources.
This study aimed to evaluate the efficacy and safety of a novel surgical technique involving the creation of a distal splenic artery-to-vein shunt for reducing the incidence of graft arteriovenous thrombosis in pancreas transplantation. This was a single-center retrospective analysis. Between November 2023 and August 2025, a modified procedure was performed in 35 patients undergoing pancreas transplantation. Graft function and shunt patency were assessed by monitoring blood glucose, serum enzymology, color Doppler ultrasonography, and computed tomography perfusion imaging. All 35 procedures were completed successfully. No graft arteriovenous thrombosis was observed during follow-up. Patent shunts were confirmed by imaging in all cases. Two non-thrombotic postoperative complications occurred (one case of gastrointestinal bleeding and one case of intestinal leakage), both of which were successfully managed with conservative treatment. Endocrine and exocrine functions of all pancreatic grafts remained normal throughout follow-up. Creation of a distal splenic arteriovenous shunt during pancreas transplantation is a safe and feasible technical innovation. By modifying splenic arteriovenous hemodynamics, this technique significantly reduces the risk of early arteriovenous thrombosis without increasing surgical complications or the complexity of anticoagulation management, demonstrating promising clinical application prospects.
No takes yet. Share an insight, caveat, or question.
Yin et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: